Teva announces FDA approval of AUSTEDO™ (deutetrabenazine) tablets for the treatment of chorea associated with Huntington's disease
admin 5th April 2017 Uncategorised 0Teva Pharmaceutical Industries
More: Teva announces FDA approval of AUSTEDO™ (deutetrabenazine) tablets for the treatment of chorea associated with Huntington's disease
Source: MDlinx